Evidence map›Paper›PMID 32102985›Full record

ArticleJCI insight2020

FPR-1 is an important regulator of neutrophil recruitment and a tissue-specific driver of pulmonary fibrosis.

Jack Leslie, Ben Jm Millar, Alicia Del Carpio Pons, Rachel A Burgoyne, Joseph D Frost, Ben S Barksby, Saimir Luli, Jon Scott, A John Simpson, Jack Gauldie and 12 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 98 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Heterozygous variants in DOCK2 leading to susceptibility to viral illnesses.The Journal of allergy and clinical immunology · 2026
    Article
  5. Article
  6. Galectin-9Aging cell · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. GPCRs as key regulators in wound healing.Frontiers in cell and developmental biology · 2026
    Review
  14. Article
  15. Mesenchymal stromal cell extracellular vesicles reduceAmerican journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Let-7b-5p loaded Mesenchymal Stromal Cell Extracellular Vesicles reducebioRxiv : the preprint server for biology · 2025
    Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 3 countries.

Jack LeslieNewcastle Fibrosis Research Group and.
Ben Jm MillarNewcastle Fibrosis Research Group and.
Alicia Del Carpio PonsNewcastle Fibrosis Research Group and.
Rachel A BurgoyneNewcastle Fibrosis Research Group and.
Joseph D FrostNewcastle Fibrosis Research Group and.
Ben S BarksbyNewcastle Fibrosis Research Group and.
Saimir LuliNewcastle Fibrosis Research Group and.
Jon ScottTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
A John SimpsonTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
Jack GauldieFirestone Institute for Respiratory Health, Saint Joseph's Healthcare and Department of Pathology and Molecular Medicine, McMaster University Hamilton, Hamilton, Ontario, Canada.
Lynne A MurrayMedImmune Ltd., Cambridge, United Kingdom.
Donna K FinchMedImmune Ltd., Cambridge, United Kingdom.
Alan M CarruthersMedImmune Ltd., Cambridge, United Kingdom.
John FergusonMedImmune Ltd., Cambridge, United Kingdom.
Matthew A SleemanMedImmune Ltd., Cambridge, United Kingdom.
David RiderMedImmune Ltd., Cambridge, United Kingdom.
Rachel HowarthNewcastle Fibrosis Research Group and.
Christopher FoxNewcastle Fibrosis Research Group and.
Fiona OakleyNewcastle Fibrosis Research Group and.
Andrew J FisherNewcastle Fibrosis Research Group and.
Derek A MannNewcastle Fibrosis Research Group and.
Lee A BorthwickNewcastle Fibrosis Research Group and.
Cystic Fibrosis Research Foundation · ITFreeman Hospital · GBNewcastle University · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBSt. Joseph’s Healthcare Hamilton · CA

Funding

Cancer Research UK 23390Cancer Research UK C18342/A23390Medical Research Council MR/K001949/1Medical Research Council MR/R023026/1Wellcome TrustWellcome Trust 204787/Z/16/Z
6 · The paper itself

Abstract

Neutrophils are the most abundant inflammatory cells at the earliest stages of wound healing and play important roles in wound repair and fibrosis. Formyl peptide receptor 1 (FPR-1) is abundantly expressed on neutrophils and has been shown to regulate their function, yet the importance of FPR-1 in fibrosis remains ill defined. FPR-1-deficient (fpr1-/-) mice were protected from bleomycin-induced pulmonary fibrosis but developed renal and hepatic fibrosis normally. Mechanistically, we observed a failure to effectively recruit neutrophils to the lungs of fpr1-/- mice, whereas neutrophil recruitment was unaffected in the liver and kidney. Using an adoptive transfer model we demonstrated that the defect in neutrophil recruitment to the lung was intrinsic to the fpr1-/- neutrophils, as C57BL/6 neutrophils were recruited normally to the damaged lung in fpr1-/- mice. Finally, C57BL/6 mice in which neutrophils had been depleted were protected from pulmonary fibrosis. In conclusion, FPR-1 and FPR-1 ligands are required for effective neutrophil recruitment to the damaged lung. Failure to recruit neutrophils or depletion of neutrophils protects from pulmonary fibrosis.

Indexed as

AnimalsBleomycinHumansLigandsMice, Inbred C57BLMice, KnockoutNeutrophil InfiltrationPulmonary FibrosisReceptors, Formyl PeptideBleomycinFPR1 protein, humanLigandsReceptors, Formyl PeptideCell BiologyFibrosisImmunologyNeutrophils

Identifiers

PMID32102985
PMCPMC7101152
OpenAlexW3006884830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.